The Nucleic Acid-Based Drugs market was valued at USD 32.05 Million in 2022 and is expected to reach USD 135.97 Million by 2030, growing at a CAGR of 19.8% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)